Development and characterization of a novel drug nanocarrier for oral delivery, based on self-assembled β-casein micelles

Journal of Controlled Release

Volumn 160, Issue 2, 2012, Pages 164-171

  Bachar, Michal ^a   Mandelbaum, Amitai ^a   Portnaya, Irina ^a   Perlstein, Hadas ^b   Even Chen, Simcha ^b   Barenholz, Yechezkel ^b   Danino, Dganit ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Amphiphilic block copolymers; Celecoxib; Drug delivery; Nanomedicine; Protein micelles

Indexed keywords

AMPHIPHILIC BLOCK COPOLYMERS; AMPHIPHILICS; ANTI-INFLAMMATORIES; ANTICANCER DRUG; CASEIN MICELLES; CELECOXIB; CORE-SHELL; CRYO-TEM; CRYOPROTECTANTS; DOSAGE FORMS; DRUG ENCAPSULATION; ENCAPSULATED DRUGS; HIGH LOADINGS; HYDROPHOBIC DRUG; MODEL DRUGS; NANOCARRIERS; ORAL ADMINISTRATION; ORAL DELIVERY; ORAL DRUG DELIVERY; RHEUMATOID ARTHRITIS; SELF-ASSEMBLED;

BLOCK COPOLYMERS; CASEIN; DRUG DELIVERY; ENCAPSULATION; MEDICAL NANOTECHNOLOGY; MICELLES; X RAY DIFFRACTION;

DRUG DOSAGE;

BETA CASEIN; CELECOXIB; NANOCARRIER;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FREEZE DRYING; MOLECULAR STABILITY; NANOENCAPSULATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASEINS; CHEMISTRY, PHARMACEUTICAL; CRYOELECTRON MICROSCOPY; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DESIGN; FREEZE DRYING; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICELLES; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR STRUCTURE; NANOPARTICLES; PYRAZOLES; SOLUBILITY; SULFONAMIDES; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS; X-RAY DIFFRACTION;

EID: 84861702785     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.01.004     Document Type: Article

References (51)

1. B. Ribadeau Dumas Primary structure of bovine beta casein. Complete sequence Eur. J. Biochem. 25 3 1972 505 514
2. H.M. Farrell Secondary structural studies of bovine caseins: temperature dependence of beta-casein structure as analyzed by circular dichroism and FTIR spectroscopy and correlation with micellization Food Hydrocolloids 15 4-6 2001 341 354
3. P. Tompa Intrinsically unstructured proteins Trends Biochem. Sci. 27 10 2002 527 533
4. A.K. Dunker Intrinsically disordered protein J. Mol. Graph. Model. 19 1 2001 26 59
5. A.L. Andrews Conformation and aggregation of bovine beta-casein-A. 1. Molecular aspects of thermal aggregation Biopolymers 18 5 1979 1105 1121
6. K. Kajiwara Micellar structure of beta-casein observed by small-angle X-ray-scattering Biochim. Biophys. Acta 955 2 1988 128 134
7. A. Thurn, W. Burchard, and R. Niki Structure of casein micelles. 1. Small-angle neutron-scattering and light-scattering from beta-casein and kappa-casein Colloid Polym. Sci. 265 8 1987 653 666
8. H.E. Swaisgood Chemistry of the caseins P.L.P.F.F.a.H. McSweeney, Advanced Dairy Chemistry 2003 Kluwer Academic/Plenum Publishers New York 139 201
9. C.D. Syme A Raman optical activity study of rheomorphism in caseins, synucleins and tau - new insight into the structure and behaviour of natively unfolded proteins Eur. J. Biochem. 269 1 2002 148 156
10. P.X. Qi, E.D. Wickham, and H.M. Farrell Thermal and alkaline denaturation of bovine beta-casein Protein J. 23 6 2004 389 402
11. H.M. Farrell Molten globule structures in milk proteins: implications for potential new structure-function relationships J. Dairy Sci. 85 3 2002 459 471
12. G.P. Berry, and L.K. Creamer Association of bovine beta-casein - importance of C-terminal region Biochemistry 14 16 1975 3542 3545
13. C.G. de Kruif, and V.Y. Grinberg Micellization of beta-casein Colloids Surf. A Physicochem. Eng. Asp. 210 2-3 2002 183 190
14. L.M. Mikheeva Thermodynamics of micellization of bovine beta-casein studied by high-sensitivity differential scanning calorimetry Langmuir 19 7 2003 2913 2921
15. J.E. O'Connell, V.Y. Grinberg, and C.G. de Kruif Association behavior of beta-casein J. Colloid Interface Sci. 258 1 2003 33 39
16. C. Moitzi Effect of temperature on self-assembly of bovine beta-casein above and below isoelectric pH. Structural analysis by cryogenic-transmission electron microscopy and small-angle X-ray scattering Langmuir 24 7 2008 3020 3029
17. I. Portnaya Self-assembly of bovine beta-casein below the isoelectric pH J. Agric. Food Chem. 56 6 2008 2192 2198
18. D.S. Horne Casein structure, self-assembly and gelation Curr. Opin. Colloid Interface Sci. 7 5-6 2002 456 461
19. I. Portnaya Micellization of bovine beta-casein studied by isothermal titration microcalorimetry and cryogenic transmission electron microscopy J. Agric. Food Chem. 54 15 2006 5555 5561
20. D.S. Horne Casein interactions: casting light on the black boxes, the structure in dairy products Int. Dairy J. 8 3 1998 171 177
21. A.O. Elzoghby, W.S. El-Fotoh, and N.A. Elgindy Casein-based formulations as promising controlled release drug delivery systems J. Control. Release 153 3 2011 206 216
22. A. Harada, and K. Kataoka Supramolecular assemblies of block copolymers in aqueous media as nanocontainers relevant to biological applications Prog. Polym. Sci. 31 11 2006 949 982
23. G. Gaucher Block copolymer micelles: preparation, characterization and application in drug delivery J. Control. Release 109 1-3 2005 169 188
24. C. Allen, D. Maysinger, and A. Eisenberg Nano-engineering block copolymer aggregates for drug delivery Colloids Surf. B Biointerfaces 16 1-4 1999 3 27
25. M.W. Matsen, and F.S. Bates Origins of complex self-assembly in block copolymers Macromolecules 29 23 1996 7641 7644
26. P. Satturwar pH-responsive polymeric micelles of poly(ethylene glycol)-b-poly(alkyl(meth)acrylate-co-methacrylic acid): influence of the copolymer composition on self-assembling properties and release of candesartan cilexetil Eur. J. Pharm. Biopharm. 65 3 2007 379 387
27. G. Gaucher Polymeric micelles for oral drug delivery Eur. J. Pharm. Biopharm. 76 2 2010 147 158
28. M.F. Francis, M. Cristea, and F.M. Winnik Polymeric micelles for oral drug delivery: why and how Pure Appl. Chem. 76 7-8 2004 1321 1335
29. G.L. Amidon A theoretical basis for a biopharmaceutic drug classification - the correlation of in-vitro drug product dissolution and in-vivo bioavailability Pharm. Res. 12 3 1995 413 420
30. M.C. Branco, and J.P. Schneider Self-assembling materials for therapeutic delivery Acta Biomater. 5 3 2009 817 831
31. V.P. Torchilin Micellar nanocarriers: pharmaceutical perspectives Pharm. Res. 24 1 2007 1 16
32. http://www.cdc.gov/h1n1flu/guidelines-labworkers.htm
33. M. Morgen Polymeric nanoparticles for increased oral bioavailability and rapid absorption using celecoxib as a model of a low-solubility, high-permeability drug Pharm. Res. 2011 10.1007/s11095-011-0558-7
34. S.K. Paulson Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption J. Pharmacol. Exp. Ther. 297 2 2001 638 645
35. S. Tacconelli The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activity Curr. Med. Res. Opin. 18 8 2002 503 511
36. F.E. Silverstein Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - the CLASS study: a randomized controlled trial JAMA 284 10 2000 1247 1255
37. M.M. Bertagnolli Celecoxib for the prevention of sporadic colorectal adenomas N. Engl. J. Med. 355 9 2006 873 884
38. P.M. Kearney Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials Br. Med. J. 332 7553 2006 1302 1305
39. C.H. Hennekens, and S. Borzak Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease J. Cardiovasc. Pharmacol. Ther. 13 1 2008 41 50
40. Trelle, S., et al., Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 342: p. Article No.: c7086 (2011).
41. P. McGettigan, and D. Henry Cardiovascular risk and inhibition of cyclooxygenase - a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase JAMA 296 13 2006 1633 1644
42. Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen or Naproxen (PRECISION) Available from: http://clinicaltrials.gov/ct/ show/NCT00346216?order=13
43. H.C. Chuang COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro Mol. Cancer 7 2008 1 13
44. J.R. Bellare Controlled environment vitrification system - an improved sample preparation technique J. Electron Microsc. Tech. 10 1 1988 87 111
45. D. Danino, A. Bernheim-Groswasser, and Y. Talmon Digital cryogenic transmission electron microscopy: an advanced tool for direct imaging of complex fluids Colloids Surf. A Physicochem. Eng. Asp. 183 2001 113 122
46. N. Seedher, and S. Bhatia Solubility enhancement of Cox-2 inhibitors using various solvent systems AAPS PharmSciTech 4 3 2003 E33
47. K. Margulis-Goshen Formation of celecoxib nanoparticles from volatile microemulsions Int. J. Pharm. 393 1-2 2010 230 237
48. S.Y. Cheng Synthesis, characterization and preliminary analysis of in vivo biological activity of chitosan/celecoxib microcapsules Bioorg. Med. Chem. Lett. 20 14 2010 4147 4151
49. N. Garti, M. Avrahami, and A. Aserin Improved solubilization of Celecoxib in U-type nonionic microemulsions and their structural transitions with progressive aqueous dilution J. Colloid Interface Sci. 299 1 2006 352 365
50. M. Nasr In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration AAPS PharmSciTech 11 1 2010 85 89
51. A. Shapira, Y.G. Assaraf, and Y.D. Livney Beta-casein nanovehicles for oral delivery of chemotherapeutic drugs Nanomed. Nanotechnol. Biol. Med. 6 1 2010 119 126